UC Irvine TODAY UC Irvine homepage UC Irvine TODAY




Sunday, September 14, 2014

News Brief

Email this page to a friend EmailPrinter friendly page PrintShare Share
March 17, 2011 4:40 p.m.

Plaque-blocking compound may aid Alzheimer's treatment »

Kim Green
Researchers with the Institute for Memory Impairments and Neurological Disorders (UCI MIND) have discovered how a novel compound can reduce the accumulation of brain plaques seen in Alzheimer's without the side effects produced by current drugs used for the chronic neurodegenerative disease. In a study published online in the Annals of Neurology, neurobiologists Kim Green and Frank LaFerla found that the ST101 compound triggers a process that carves up amyloid precursor proteins into benign molecules. These precursor proteins, when intact, ultimately can form into beta-amyloid plaques, which are the hallmark lesions of Alzheimer's and believed to be the primary cause of dementia. The researchers believe ST101 could be the basis of a drug therapy for people with mild Alzheimer's symptoms.

Media Contact
Related topics: Research, Alzheimer's, UCI MIND, Neuroscience, Health & Medicine, Faculty, Medicine, Biological Sciences, Brain & Memory
University of California, Irvine
University of California, Irvine - Irvine, CA 92697 : 949-824-5011
Comments & Questions | Privacy & Legal Notice | Copyright Inquiries | © 2014 UC Regents